<!-- PageNumber="54" -->
<!-- PageHeader="Basic Research in Cardiology, Vol. 94, No. 1 (1999) Â© Steinkopff Verlag 1999" -->


Table 3 Myocardial blood flow in subepicardial and subendocardial septum

| Patient | Symptoms | basal endo | basal epi | dip endo | dip epi | post basal endo | post basal epi | post dip endo | post dip epi | Pre basal Endo/Epi | Post basal Endo/Epi | Pre dip Endo/Epi | Post dip Endo/Epi | CFR endo pre | CFR epi pre | endo post | CFR epi post |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1 | A | 1.46 | 1.41 | 1.17 | 1.75 | 0.94 | 0.74 | 0.93 | 0.89 | 1.03 | 1.26 | 0.67 | 1.07 | 0.80 | 1.24 | 0.99 | 1.19 |
| 2 | A | 0.98 | 1.02 | 0.86 | 1.08 | 0.78 | 0.78 | 0.91 | 0.93 | 0.96 | 1.00 | 0.79 | 0.97 | | 1.06 | 1.16 | 1.20 |
| 3 | B | 0.76 | 0.59 | 0.78 | 0.73 | 0.76 | 0.68 | 0.61 | 0.92 | 1.28 | 1.12 | 1.26 | 0.91 | 1.02 | 1.22 | 0.79 | 1.34 |
| 4 | - | 0.80 | 0.81 | 0.79 | 0.89 | - | - | - | - | 0.99 | - | 0.77 | - | 0.98 | 1.09 | | |
| 5 | A | 1.36 | 0.82 | 1.32 | 1.56 | 0.79 | 0.80 | 1.42 | 2.16 | 1.67 | 0.99 | 0.84 | 0.66 | 0.97 | 1.91 | 1.80 | 2.70 |
| 6 | A | 0.93 | 0.87 | 1.24 | 1.56 | 1.87 | 1.40 | 1.62 | 1.18 | 1.07 | 1.34 | 0.81 | 1.38 | 1.33 | 1.79 | 0.86 | 0.84 |
| 7 | A | 1.33 | 1.25 | 1.00 | 1.59 | 1.56 | 1.24 | 0.94 | 1.23 | 1.07 | 1.26 | 0.64 | 0.78 | 0.75 | 1.27 | 0.60 | 0.99 |
| 8 | B | 0.56 | 0.47 | 1.22 | 1.11 | 0.56 | 0.51 | 1.04 | 1.04 | 1.21 | 1.09 | 1.09 | 1.00 | 2.16 | 2.38 | 1.86 | 2.03 |
| 9 | B | 0.90 | 0.90 | 0.90 | 1.47 | 0.75 | 0.76 | 1.41 | 1.42 | 1.01 | 0.98 | 0.62 | 1.00 | 1.00 | 1.63 | 1.89 | 1.87 |
| 10 | B | 0.67 | 0.63 | 1.57 | 1.92 | 1.14 | 1.01 | 1.27 | 1.18 | 1.06 | 1.13 | 0.82 | 1.09 | 2.33 | 3.02 | 1.11 | 1.16 |
| 11 | A | 1.22 | 1.18 | 1.46 | 1.25 | 1.21 | 1.42 | 1.74 | 1.62 | 1.04 | 0.85 | 1.22 | 1.18 | 1.19 | 1.06 | 1.43 | 1.14 |
| 12 | B | 1.12 | 0.94 | 1.21 | 1.15 | 0.88 | 0.70 | 1.78 | 1.20 | 1.20 | 1.26 | 1.05 | 1.51 | 1.07 | 1.22 | 2.03 | 1.71 |
| 13 | A | 0.86 | 0.74 | 1.08 | 0.93 | 1.05 | 0.93 | 1.08 | 0.83 | 1.17 | 1.13 | 1.15 | 1.30 | 1.25 | 1.26 | 1.03 | 0.89 |
| 14 | A | 1.35 | 1.14 | 1.93 | 1.39 | 1.59 | 1.00 | 1.25 | 1.05 | 1.19 | 1.59 | 1.39 | 1.17 | 1.43 | 1.22 | 0.78 | 1.05 |
| 15 | B | 0.69 | 0.69 | 0.95 | 1.19 | 0.85 | 0.55 | 0.83 | 1.05 | 1.00 | 1.56 | 0.80 | 0.80 | 1.37 | 1.71 | 0.97 | 1.92 |
| Mean | | 1.00 | 0.90 | 1.16 | 1.30 | 1.05 | 0.89 | 1.20 | 1.19 | 1.13 | 1.18 | 0.93 | 1.06 | 1.24 | 1.54 | 1.24 | 1.43 |
| SD | | 0.29 | 0.26 | 0.32 | 0.34 | 0.38 | 0.29 | 0.36 | 0.35 | 0.18 | 0.21 | 0.24 | 0.24 | 0.46 | 0.56 | 0.47 | 0.54 |

Key: Symptoms = change in symptomatic status after verapamil; A = improved $\left( n = 8 \right)$ ; B = worsened or no change $\left( n = 6 \right)$ ; $\mathrm { d i p } =$ dipyridamole; bas
= baseline; endo = subendocardial; epi = subepicardial; Endo/Epi = subendocardial/subepicardial flow ratio; pre/post = pre and post verapamil therapy
respectively; CFR = coronary flow reserve (dipyridamole/baseline myocardial blood flow). All values of myocardial blood flow are in ml/min/g


Fig. 3 Values of myocardial
blood flow (MBF) are shown
for subendocardial (endo) and
subepicardial (epi) septal regions
before and after treatment in
patients that improved symptomatically following drug therapy
(group A) and in those that
reported no change or a worsening
of symptoms (group B).
All values represent mean + 1
standard deviation.

![2.00 *** **** 1.50 MBF (ml/min/g) 1.00 Group A T Group B 0.50 * $$p = 0 . 0 0 6 ;$$
$$p = 0 . 0 0 5 ;$$
$$p = 0 . 0 3 ;$$
$$\mathrm { p } = 0 . 0 2$$ 0.00 Basal endo Basal epi Dip endo Dip epi Basal endo Basal epi Dip endo Dip epi Pre-treatment Post-treatment](figures/1.1)
```